Patents by Inventor Omar Kabbarah

Omar Kabbarah has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • THERAPEUTIC, DIAGNOSTIC, AND PROGNOSTIC METHODS FOR CANCER
    Publication number: 20230220491
    Abstract: The invention provides methods and compositions to detect expression of one or more biomarkers, including FGFR3, TP53, and/or EGFR, for treating, diagnosing, and providing a prognosis for cancer, e.g., bladder cancer. The invention also provides kits and articles of manufacture for use in the methods.
    Type: Application
    Filed: January 20, 2023
    Publication date: July 13, 2023
    Inventors: YounJeong CHOI, Omar Kabbarah, Doris Kim
  • THERAPEUTIC, DIAGNOSTIC, AND PROGNOSTIC METHODS FOR CANCER
    Publication number: 20220267864
    Abstract: The invention provides methods and compositions to detect expression of one or more biomarkers, including FGFR3, TP53, and/or EGFR, for treating, diagnosing, and providing a prognosis for cancer, e.g., bladder cancer. The invention also provides kits and articles of manufacture for use in the methods.
    Type: Application
    Filed: May 12, 2022
    Publication date: August 25, 2022
    Inventors: YounJeong CHOI, Omar KABBARAH, Doris KIM
  • COMPOSITIONS AND METHODS FOR PROSTATE CANCER ANALYSIS
    Publication number: 20200200752
    Abstract: The invention provides methods for diagnosing prostate cancer. The invention also provides methods for determining the prognosis and efficacy of STEAP1-ADC therapy in patients with prostate cancer, specifically metastatic castration resistant prostate cancer (mCRPC).
    Type: Application
    Filed: December 19, 2019
    Publication date: June 25, 2020
    Applicants: Genentech, Inc., EPIC SCIENCES INC.
    Inventors: Omar Kabbarah, Iliana Szafer-Glusman, Dena Marrinucci, Florence Lee, Shannon Werner
  • COMPOSITIONS AND METHODS FOR PROSTATE CANCER ANALYSIS
    Publication number: 20180209982
    Abstract: The invention provides methods for diagnosing prostate cancer. The invention also provides methods for determining the prognosis and efficacy of STEAP1-ADC therapy in patients with prostate cancer, specifically metastatic castration resistant prostate cancer (mCRPC).
    Type: Application
    Filed: October 20, 2017
    Publication date: July 26, 2018
    Applicants: Genentech, Inc., EPIC SCIENCES INC.
    Inventors: Omar KABBARAH, Iliana SZAFER-GLUSMAN, Dena MARRINUCCI, Florence LEE, Shannon WERNER
  • THERAPEUTIC, DIAGNOSTIC, AND PROGNOSTIC METHODS FOR CANCER
    Publication number: 20170306418
    Abstract: The invention provides methods and compositions to detect expression of one or more biornarkers, including FGFR3, TP53, and/or EGFR, for treating, diagnosing, and providing a prognosis for cancer, e.g., bladder cancer. The invention also provides kits and articles of manufacture for use in the methods.
    Type: Application
    Filed: June 21, 2017
    Publication date: October 26, 2017
    Inventors: YounJeong CHOI, Omar KABBARAH, Doris KIM
  • Compositions, Kits, and Methods for the Diagnosis, Prognosis, and Monitoring of Cancer Using GOLPH3
    Publication number: 20110262464
    Abstract: The present invention is based, in part, on the discovery that GOLPH3 plays a role in cancer, including lung, ovarian, pancreatic, liver, breast, prostate, and colon carcinomas, as well as melanoma and multiple myeloma. Accordingly, the invention relates to compositions, kits, and methods for diagnosing, prognosing, and monitoring cancer, e.g., lung, ovarian, pancreatic, liver, breast, prostate, and colon carcinomas, as well as melanoma and multiple myeloma.
    Type: Application
    Filed: October 5, 2009
    Publication date: October 27, 2011
    Applicant: DANAFARBER CANCER INSTITUTE, INC.
    Inventors: Lynda Chin, Kenneth Scott, Omar Kabbarah